Trial intelligence / Profile preview

Coload Effect on Cardiac Output in Preeclamptic Patients Undergoing Cesarean Delivery

NCT05435573Completed

Sponsor
Mansoura University
Start
Aug 2022
Primary completion
Sep 2023
Modality
Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
Countries
1
01

Overview

Trial of hetastarch in preeclampsia (2 arms), sponsored by Mansoura University. Primary endpoint: Cardiac output measurement at 1 hour. Started Aug 2022; status: completed.

02

Drugs

hetastarch
03

Conditions

preeclampsia

Beyond the preview

Go deeper on NCT05435573.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05435573.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call